Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5'-AMP-activated protein kinase (AMPK) is a heterotrimeric enzyme complex consisting of alpha, beta, and gamma subunits that serves as a master regulator of cellular energy homeostasis (Hardie et al., 2012; Nat Rev Mol Cell Biol). The holoenzyme containing the beta-1 regulatory subunit (PRKAB1) is of particular therapeutic interest due to its high expression in the liver and its role in mediating the effects of specific small-molecule activators (UniProt P80331). The beta-1 subunit contains a carbohydrate-binding module (CBM) that, together with the alpha-subunit kinase domain, forms the Allosteric Drug and Metabolite (ADaM) site (Hawley et al., 2012; Science). Activation of beta-1-containing AMPK complexes promotes catabolic processes such as fatty acid oxidation and glucose uptake while suppressing anabolic pathways like lipogenesis and gluconeogenesis (Cool et al., 2006; Cell Metab). Consequently, this target is being actively investigated for the treatment of metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH). Drugs like salicylate and synthetic activators like A-769662 specifically target the beta-1 subunit to enhance AMPK activity and improve metabolic health (Myers et al., 2017; Science). This subunit-specific targeting is thought to offer a therapeutic window by focusing activity on metabolic tissues while potentially avoiding cardiac side effects associated with other isoforms.
Direct allosteric activation via binding to the Allosteric Drug and Metabolite (ADaM) site, which is formed by the interface of the alpha-subunit kinase domain and the beta-subunit carbohydrate-binding module (Hawley et al., 2012; Science). This binding also protects the alpha-subunit Thr172 from dephosphorylation by protein phosphatases (Hunter et al., 2014; Chem Biol).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5'-AMP-activated protein kinase holoenzyme containing the beta-1 regulatory subunit (AMPK-beta1) (AMPK-beta1).